摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-N-benzyl-3-(6-methoxynaphth-2-yl)-N-methylbut-2-en-1-amine hydrochloride | 1219009-26-3

中文名称
——
中文别名
——
英文名称
(E)-N-benzyl-3-(6-methoxynaphth-2-yl)-N-methylbut-2-en-1-amine hydrochloride
英文别名
——
(E)-N-benzyl-3-(6-methoxynaphth-2-yl)-N-methylbut-2-en-1-amine hydrochloride化学式
CAS
1219009-26-3
化学式
C23H25NO*ClH
mdl
——
分子量
367.919
InChiKey
JMPRRWFCPACEBE-PUBYZPQMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

反应信息

  • 作为反应物:
    描述:
    (E)-N-benzyl-3-(6-methoxynaphth-2-yl)-N-methylbut-2-en-1-amine hydrochloride氢气乙二胺 作用下, 以 乙醇 为溶剂, 以46%的产率得到rac-N-benzyl-3-(6-methoxynaphth-2-yl)-N-methylbutan-1-amine
    参考文献:
    名称:
    Design, synthesis and SAR analysis of novel selective σ1 ligands (Part 2)
    摘要:
    In order to investigate the molecular features involved in sigma receptors (sigma-Rs) binding, new compounds based on arylalkylaminoalcoholic, arylalkenyl- and arylalkylaminic scaffolds were synthesized and their affinity towards sigma(1)- and sigma(2)-Rs subtypes was evaluated. The most promising compounds were also screened for their affinity at mu-opioid, delta-opioid and kappa-opioid receptors. Biological results are herein presented and discussed. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2009.12.039
  • 作为产物:
    描述:
    N-benzyl-3-(6-methoxynaphth-2-yl)-N-methylbut-2-en-1-amine 在 盐酸 作用下, 以 为溶剂, 生成 (E)-N-benzyl-3-(6-methoxynaphth-2-yl)-N-methylbut-2-en-1-amine hydrochloride
    参考文献:
    名称:
    Design, synthesis and SAR analysis of novel selective σ1 ligands (Part 2)
    摘要:
    In order to investigate the molecular features involved in sigma receptors (sigma-Rs) binding, new compounds based on arylalkylaminoalcoholic, arylalkenyl- and arylalkylaminic scaffolds were synthesized and their affinity towards sigma(1)- and sigma(2)-Rs subtypes was evaluated. The most promising compounds were also screened for their affinity at mu-opioid, delta-opioid and kappa-opioid receptors. Biological results are herein presented and discussed. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2009.12.039
点击查看最新优质反应信息